Lea Winerman
By Lea Winerman
-
News Doctor Looks to Ashkenazim in Search for Schizophrenia Cure
Epidemiologist Ann Pulver found her research calling early. As an undergraduate at Boston University, she worked with schizophrenia patients and saw firsthand the devastation the disease can cause. She decided then to devote her career to fighting it. Now, as head of the epidemiology-genetics program in psychiatry at Johns Hopkins University, Pulver is doing just…
-
Culture A New Treatment for Gaucher? Compound Intrigues
Researchers have developed a chemical compound that could lead to a new treatment for Gaucher disease, the most common genetic disease among Ashkenazi Jews, which causes problems including anemia, poor blood clotting, an enlarged liver and spleen, bone damage and, in the most serious cases, neurological problems. The newly discovered compound is made up of…
-
Culture Usher Gene Discovered
Scientists have pinpointed the gene mutation responsible for most cases of Usher syndrome type 1 in Ashkenazi Jews. The syndrome is a genetic disorder that causes deafness from birth and progressive blindness beginning before age 10. The discovery, first reported in The New England Journal of Medicine in April, will allow doctors to more easily…
Explore
Most Popular
- 1
Opinion The Germans have a word for what’s happening in Trump’s America
- 2
News Why the ADL is encouraging Jews to invest in Tesla
- 3
Fast Forward It was a historic Jewish night at the Oscars. Why are so many Jews outraged?
- 4
Opinion To avoid a showdown with Vance and Trump, Zelenskyy should have channeled Netanyahu
In Case You Missed It
-
Yiddish World ‘Shtisel’ spin-off ‘Kugel’ richly portrays a diasporic Hasidic community
-
Art Why Queen Esther was the star in the age of Rembrandt’s Amsterdam
-
News Trump promised to protect Jews and religious liberty. His refugee ban is keeping out 700 persecuted Iranian Jews.
-
Film & TV In a Trumpian Hollywood, men honored for playing tortured geniuses, women for playing sex workers
-
Shop the Forward Store
100% of profits support our journalism
